Full View

First‐pass CYP3A‐mediated metabolism of midazolam in the gut wall and liver in preterm neonates

JM Brussee, H Yu, EHJ Krekels… - CPT …, 2018 - Wiley Online Library
To predict first‐pass and systemic cytochrome P450 (CYP) 3A‐mediated metabolism of
midazolam in preterm neonates, a physiological population pharmacokinetic model was …
被引用次数：32 相关文章
[PDF] core.ac.uk

[PDF][PDF] First-Pass CYP3A-Mediated Metabolism of Midazolam in the Gut Wall and Liver in Preterm Neonates

JM Brussee, H Yu, EHJ Krekels, B de Roos, MJE Brill… - core.ac.uk
To predict first-pass and systemic cytochrome P450 (CYP) 3A-mediated metabolism of
midazolam in preterm neonates, a physiological population pharmacokinetic model was …

First-Pass CYP3A-Mediated Metabolism of Midazolam in the Gut Wall and Liver in Preterm Neonates

JM Brussee, H Yu, EHJ Krekels… - CPT …, 2018 - pubmed.ncbi.nlm.nih.gov
To predict first-pass and systemic cytochrome P450 (CYP) 3A-mediated metabolism of
midazolam in preterm neonates, a physiological population pharmacokinetic model was …

First-Pass CYP3A-Mediated Metabolism of Midazolam in the Gut Wall and Liver in Preterm Neonates

JM Brussee, H Yu, EHJ Krekels, B de Roos… - CPT: Pharmacometrics …, 2018 - diva-portal.org
To predict first-pass and systemic cytochrome P450 (CYP) 3A-mediated metabolism of
midazolam in preterm neonates, a physiological population pharmacokinetic model was …
[HTML] nih.gov

[HTML][HTML] First‐Pass CYP3A‐Mediated Metabolism of Midazolam in the Gut Wall and Liver in Preterm Neonates

JM Brussee, H Yu, EHJ Krekels, B de Roos… - CPT …, 2018 - ncbi.nlm.nih.gov
To predict first‐pass and systemic cytochrome P450 (CYP) 3A‐mediated metabolism of
midazolam in preterm neonates, a physiological population pharmacokinetic model was …
[PDF] universiteitleiden.nl

[PDF][PDF] First-Pass CYP3A-Mediated Metabolism of Midazolam in the Gut Wall and Liver in Preterm Neonates

JM Brussee, H Yu, EHJ Krekels, B de Roos, MJE Brill… - scholarlypublications …
To predict first-pass and systemic cytochrome P450 (CYP) 3A-mediated metabolism of
midazolam in preterm neonates, a physiological population pharmacokinetic model was …

First-Pass CYP3A-Mediated Metabolism of Midazolam in the Gut Wall and Liver in Preterm Neonates

J Brussee, H Yu, E Krekels, B de Roos… - CPT: Pharmacometrics …, 2018 - repub.eur.nl
To predict first-pass and systemic cytochrome P450 (CYP) 3A-mediated metabolism of
midazolam in preterm neonates, a physiological population pharmacokinetic model was …

First‐Pass CYP3A‐Mediated Metabolism of Midazolam in the Gut Wall and Liver in Preterm Neonates

JM Brussee, H Yu, EHJ Krekels… - CPT …, 2018 - search.proquest.com
To predict first‐pass and systemic cytochrome P450 (CYP) 3A‐mediated metabolism of
midazolam in preterm neonates, a physiological population pharmacokinetic model was …

First-Pass CYP3A-Mediated Metabolism of Midazolam in the Gut Wall and Liver in Preterm Neonates.

JM Brussee, H Yu, EHJ Krekels, B de Roos… - CPT …, 2018 - europepmc.org
To predict first‐pass and systemic cytochrome P450 (CYP) 3A‐mediated metabolism of
midazolam in preterm neonates, a physiological population pharmacokinetic model was …
[PDF] ru.nl

[PDF][PDF] First-Pass CYP3A-Mediated Metabolism of Midazolam in the Gut Wall and Liver in Preterm Neonates

JM Brussee, H Yu, EHJ Krekels, B Roos, MJE Brill… - 2018 - repository.ubn.ru.nl
To predict first-pass and systemic cytochrome P450 (CYP) 3A-mediated metabolism of
midazolam in preterm neonates, a physiological population pharmacokinetic model was …